NetworkNewsBreaks – Healthtech Solutions Inc. (H
Post# of 26
(Total Views: 152)
Posted On: 07/01/2021 4:11:56 PM
NetworkNewsBreaks – Healthtech Solutions Inc. (HLTT) Announces New COO, New Board Member
Healthtech Solutions (OTC: HLTT), an innovative portfolio-model life sciences company focused on building impactful solutions for patients and the healthcare system through its subsidiary companies ranging in stage from preclinical to commercial growth, has named Brad Mathis as its new chief operating officer and Ryan Salomone as a new member of the company’s board of directors. Mathis and Salomone have decades of experience in the healthcare, pharmaceutical and biotech industries, and their appointments broaden the company’s leadership teams. Mathis comes from Argenx Inc., where he most recently served as vice president and general manager of the company’s US Neurology franchise; he also held positions of responsibility at Amgen, Celgene, Biogen and BMS. Mathis has been involved in a number of successful product launches and led multiple cross-functional teams. Salomone brings more than a decade of experience working at Fidelity Institutional Asset Management with a focus on healthcare investing; his most recent role was as a senior healthcare analyst on the small cap team. Salomone also co-founded an asset management firm focused on systematically managed investment strategies, where he serves as the chief investment officer. “We could not be more thrilled to have Brad Mathis as our COO and Ryan Salomone as a director of Healthtech,” said Healthtech CEO Ned Swanson, MD, in the press release. “Their additions significantly expand our capabilities to accelerate the next advancements in healthcare with the potential to improve the lives of countless individuals. With Brad’s experience leading assets from pre-commercial stage to greater than $1.5 billion in revenue and Ryan’s experience advising funds at Fidelity with greater than $35 billion in assets under management, we know we have the right people to deliver on our vision at Healthtech.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Healthtech Solutions (OTC: HLTT), an innovative portfolio-model life sciences company focused on building impactful solutions for patients and the healthcare system through its subsidiary companies ranging in stage from preclinical to commercial growth, has named Brad Mathis as its new chief operating officer and Ryan Salomone as a new member of the company’s board of directors. Mathis and Salomone have decades of experience in the healthcare, pharmaceutical and biotech industries, and their appointments broaden the company’s leadership teams. Mathis comes from Argenx Inc., where he most recently served as vice president and general manager of the company’s US Neurology franchise; he also held positions of responsibility at Amgen, Celgene, Biogen and BMS. Mathis has been involved in a number of successful product launches and led multiple cross-functional teams. Salomone brings more than a decade of experience working at Fidelity Institutional Asset Management with a focus on healthcare investing; his most recent role was as a senior healthcare analyst on the small cap team. Salomone also co-founded an asset management firm focused on systematically managed investment strategies, where he serves as the chief investment officer. “We could not be more thrilled to have Brad Mathis as our COO and Ryan Salomone as a director of Healthtech,” said Healthtech CEO Ned Swanson, MD, in the press release. “Their additions significantly expand our capabilities to accelerate the next advancements in healthcare with the potential to improve the lives of countless individuals. With Brad’s experience leading assets from pre-commercial stage to greater than $1.5 billion in revenue and Ryan’s experience advising funds at Fidelity with greater than $35 billion in assets under management, we know we have the right people to deliver on our vision at Healthtech.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)